Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 5 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 11077175

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  2. US 11052060

    Compounds and methods for treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  3. US 11033601

    Selective inhibition of V1b for treating fatty liver

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  4. US 11013787

    Sustained release formulation of interleukin-10 for wound treatment and related methods

    THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER · Granted May 25, 2021 · Expires May 20, 2041

    granted

  5. US 11013707

    Administration of oral methyldopa

    The Regents of the University of Colorado, a Body Corporate · Granted May 25, 2021 · Expires May 20, 2041

    granted

  6. US 10993834

    Lacrimal system drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  7. US 10947238

    Wee1 kinase inhibitors and methods of making and using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  8. US 10941392

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  9. US 10940109

    Multilayer polymeric matrix based medical devices

    The Regents of the University of Colorado · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  10. US 10913790

    Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  11. US 10912770

    Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  12. US 10912767

    Anthracycline prodrugs and methods of making and using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  13. US 10889625

    Peptide-based methods for treating neurological injury

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  14. US 10874745

    Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  15. US 10857106

    Methods and products for treating and/or delaying onset of dysplastic lesions

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  16. US 10799567

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  17. US 10799511

    Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  18. US 10791731

    Methods for preparing frozen plasma material for rapid thawing in an emergency situation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted

  19. US 10760055

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  20. US 10751408

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  21. US 10738123

    Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  22. US 10736864

    Immunotherapeutic agent

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  23. US 10729753

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  24. US 10723784

    Compositions and methods for preparing a subject for organ or non-organ implantation

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.